December 5, 2019 8:39am

After volume has dawned, after fundamentals have fawned; after the NASDAQ, XBI and IBB have spawned, is there a theme or a swan song here for “spirits” to celebrate?

Rumors abound and Investors fantasize about a U.S.-China trade “deal”; yet the term “edging” still doesn’t have a financial connotation, a maybe re consequence – it’s just more uncertainty

Pre-open indications: SELL: ReNeuron (RENE.L) – the usual rollercoaster and Sage Therapeutics (SAGE) as depression treatment fails primary endpoint; BUY: I’m the “grabby” type in profit taking; get it while you can – Global Blood Therapeutics (GBT) and uniQure (QURE) – no buyer yet but, there is accumulation!

Skim if you can trim, buy if it will fly and sell if compelled!

 

The 6 W’s: Who, what, where, when, why and what of it … so who has done what?

 

Dow futures are UP +0.31% (+87 points), S&P futures are UP +0.31% (+10 point) and NASDAQ futures are UP +0.41% (+34 points)

 

Dow futures indicated a positive open, S&P and NASDAQ futures followed with both slightly higher;

European stocks moved higher with the pan-European Stoxx 600 was +0.3% higher with most sectors trading in the black;

Asia Pacific stocks are skittish yet, mostly rose as the MSCI Asia ex-Japan index traded +0.57% higher;

 

Data Docket: weekly jobless claims and international trade figures for October will be released at 8:30 a.m. ET. Factory orders for October will follow slightly later in the session.

 

Henry’omics:

Market focus is largely attuned to global trade developments, following a media “rumors” suggesting the world’s two largest economies were on the cusp of signing a so-called “phase one” trade deal.

Jobs numbers – a good one at 8:30 a.m. – 203,000 versus 215,000; claims drop to seven (7) month low!

 

Rumors are slinging hash, reality is harsh - a heck of a lot of alliteration this a.m.!

 

Which part of last night’s post, “volume is picking up in a positive close; the second in a row of three (3) closes for the new month of December” sets the tone of today’s session?

  • The NASDAQ closed UP +46.03 points (+0.54%);
  • The IBB closed up +1.25% and the XBI closed up +1.16%
  • The close was positive with an A/D line of 24/13, 4 flats, 1 reversed merged (HSGX), 1 dropped (BTX) and 2 acquired;
  • The range of the 24 upside was +0.29% (VCEL) to +9.03% (AGTC) while the 13 downside ranged from -0.14% (VYGR) to -4.84% (AXGN); 
  • 13 out of the 24 upside had higher than the 3 month average volume;
  • 8 out of the 13 downside had higher than the 3 month average volume;

 

Review the content of Q4’s market:

  • December register 1 negative and 2 positive closes … so far
  • November registered 1 holiday, 12 positive and 8 negative close;
  • October registered 10 positive, 1 neutral and 14 negative closes;

 

Companies in my headlights – It’s your decision; I provide an idea and context:

Pre-open indications: SELL: ReNeuron (RENE.L) – the usual rollercoaster and Sage Therapeutics (SAGE) as depression treatment fails primary endpoint; BUY: I’m the “grabby” type in profit taking; get it while you can – Global Blood Therapeutics (GBT) and uniQure (QURE) – no bure yet but, there is accumulation!

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.